Purpose Hip fracture is the most common serious injury of older people, often resulting in reduced mobility and loss of independence. However, guidance for the use of patientreported outcome measures (PROMs) does not exist: we describe the first review to apply internationally endorsed criteria in support of PROM quality and acceptability in this group, and make recommendations for future applications. Methods Systematic literature searches of major databases to identify published evidence of the application and quality of clearly defined measures. Evidence of measurement and practical properties, and the extent of active patient involvement, was sought. Study and PROM quality was assessed against recommended criteria. Results Seventy-one articles relating to 28 PROMs (Generic n = 12; Specific n = 16) were included. The SF-36 (v1) and EuroQoL EQ-5D 3L were the most widely evaluated measures with acceptable evidence of measurement properties, but limited evaluations of practical properties or relevance to this group. Evidence was mostly limited for the remaining measures. Hypothesized associations between variables were infrequently evaluated. Evidence of data quality, test-retest reliability, responsiveness, interpretation, acceptability and feasibility was also limited. Active patient involvement in PROM development or evaluation was not reported. There was limited evaluation of proxy completions. Conclusions The paucity of robust evaluations is disappointing and prevents clear recommendations for PROMbased assessment. Further research must urgently seek to identify which outcomes really matter to this group. Future PROM selection must be underpinned by research which focuses on methodological quality, including issues of acceptability, relevance, feasibility of application, and proxy completion, whilst seeking to actively incorporate the perspective of patients and their advocates.
Introduction
Hip fracture is the most common serious injury of older people, often resulting in reduced mobility and loss of independence, and representing one of the greatest challenges to the healthcare community [1] . In 1990, a global incidence of 1.31 million hip fractures was reported, with an associated 740,000 deaths [2] . Hip fractures represent a growing, worldwide socioeconomic burden: current costs to England's NHS are estimated at £1.4 billion, or 1 % of the NHS budget [3] .
Traditionally, outcome assessment for patients presenting with proximal femoral fracture was focused on Electronic supplementary material The online version of this article (doi:10.1007/s11136-016-1424-1) contains supplementary material, which is available to authorized users. mortality/morbidity rates, surgical implant success or operative complications [4, 5] . However, the growing focus on patient-centred care and recognition of the importance of understanding the impact of hip fracture and associated care from the perspective of the patient has resulted in a shift in how outcomes are assessed in clinical trials, audit and routine practice settings towards the assessment of patient experience and the quality of life achieved [6] [7] [8] . The use of well-developed patient-reported outcome measures (PROMs)-single or multi-item questionnaires which seek to assess how patients feel, what they can and cannot do and how they live their lives as a consequence of their health and associated health care, could provide critical information to enhance patient-centred health care [9] . However, guidance for appropriate PROM-based assessment following hip fracture does not exist, and little is known about which outcomes are most important to patients.
Where uncertainly exists, structured reviews of evidence can be essential to informing the selection of relevant and appropriate measures. Three recent articles have reviewed the use and availability of patient-reported and clinicianreported measures following surgical interventions for hip pathology [4] and traumatic hip fracture [5, 10] . Ahmad et al. [4] suggested that the outcomes of elective or traumatic hip surgery should be assessed with a clear and concise hipspecific measure that allows consideration of co-morbidities, the use of walking aids, and includes a generic component. However, a selective review of commonly used hip-specific, disease-specific and generic measures highlighted numerous limitations-with none of the reviewed measures fulfilling the suggested requirements. Moreover, few measures had been adequately evaluated, further limiting recommendations. In conclusion, whilst recommending a combination of hip-specific (Oxford hip score-OHS), disease-specific (Western Ontario and Mcmaster university osteoarthritis index-WOMAC) and generic measures, the need for further robust evaluations was emphasized.
Hutchings et al. [5] reviewed fourteen of the most commonly used clinician-reported, performance-based and patient-reported measures in the elderly proximal hip fracture population. They highlighted significant variation in outcome reporting, with no single measure in widespread use in this population. Although the search strategies applied in pursuit of published psychometric evidence were limited [11] , concerns pertaining to the limited availability of robust evaluations by which to determine the 'validity' of measures were also raised. Cautious recommendations included: a generic measure, such as the EuroQoL EQ-5D or SF-36; a measure of activities of daily living (ADL), such as the Barthel Index; and a hip-specific measure, such as the OHS, although evidence for the latter was very limited.
A further article provides a limited review of the strengths and caveats of five named measures applicable for use in patients with hip pathology, summarizing, but not directly comparing, their suitability for use in the rheumatology community [12] . However, none of the reviews considered the methodological quality of reviewed studies, thus making it difficult to judge the strength of psychometric evidence underpinning any recommendations [13] . Evidence-based healthcare demands the critical appraisal of study methodological quality; where a study is of poor methodological quality, confidence in the results is reduced [14] . Similarly, an appreciation of the methodological quality of PROM evaluative studies is crucial to data interpretation [11, 15] . Moreover, the reviews of psychometric evidence were often limited, non-transparent and non-systematic.
The aim of this review was to critically appraise, compare and summarize the quality and acceptability of published PROMs evaluated following completion (self, interview, or proxy) by older patients (aged 60 years and above) who had sustained a hip fracture. The results of the review will assist in the selection of a PROM suitable for inclusion in routine practice, audit, or clinical research settings.
Methods

Identification of studies and PROMs: search strategy
The search strategy sought to retrieve references relating to the development and/or evaluation of multi-item PROMs used in the evaluation of older people (aged 60 years and above) who had sustained a hip fracture. Searches used medical subject headings (MeSH terms) and free text searching to combine terms specific to hip fracture with terms relevant to health measurement and PROM evaluation [11, 16] . Four databases were searched: 1980 to Aug 2015 [MEDLINE (OVID), EMBASE, CINAHL and PsychINFO]. Further database searches used names of identified PROMs. Citation lists of included articles and earlier reviews of measures used in hip pathologies or hip fracture [5, 6, 10] were reviewed.
Inclusion/exclusion criteria
All titles and abstracts were assessed for inclusion/exclusion by one reviewer (JB), a sub-set of 10 % were double assessed (JB, KH) and agreement checked. Published articles were included if they provided evidence of development/evaluation for clearly defined and reproducible multi-item PROMs, assessing single or multiple domains of health, following self, interview or proxy completion by older people (aged 60 years and above) who had sustained a hip fracture. Articles relating solely to PROM application without some evidence of measurement and/or practical properties were not included. Included PROMs were categorized as generic (profile or utility), hip-specific (surgeon or patient-completed), condition-specific, or domainspecific [16] . Proxy completion was highlighted. Evaluations in non-English speaking populations published in English-language journals were included. Single-item and mobility measures, radiographic and imaging techniques were excluded, as were measures without evidence of reliability or validity.
Data extraction and appraisal
A data extraction form, informed by key psychometric texts [17, 18] , guidance for evaluating PROM quality [19] , earlier reviews [16, 20] and the requirements of the consensus-based standards for the selection of health measurement instruments (COSMIN) checklist [15, 21] were developed. Data extraction captured both study and PROM-specific information. Evidence for measurement properties included: reliability (internal consistency, testretest, intra/inter-tester); validity (content, construct including within scale and analyses against external criteria-convergent/divergent, known groups, evidence of explicit hypothesis testing was sought); responsiveness (criterion-based or construct-based assessment [18, 21] was prioritized; reporting of effect size (ES) statistics was also extracted); interpretation (minimal important difference); and precision (data quality and end effects). Evidence for practical properties included acceptability (relevance and respondent burden) and feasibility. The extent of active patient involvement in PROM evaluation was sought [22, 23] .
Assessment of study methodological quality
The COSMIN checklist provides a consensus-based framework against which the methodological quality of PROM-based evaluative studies can be judged [15, 21] . Nine specific measurement properties are described: each checklist contains a list of items against which study methodological quality is assessed; items are scored on a 4-point rating scale (that is, excellent, good, fair, poor) [15] . Study methodological quality was evaluated per measurement property and determined by the lowest rating of any of the items in each checklist section. Two reviewers (JB, KH) independently applied the checklist to each article. Agreement was checked, and any disagreement was resolved through discussion.
Assessment of PROM quality
A similar consensus-based checklist for the appraisal of PROM quality does not exist. However, a synthesis of various recommendations was described in an earlier review [16] and provided a pragmatic checklist against which the results of PROM testing were judged.
Data synthesis
A qualitative synthesis of data per reviewed PROM informed the overall judgement of quality and acceptability. As per earlier reviews [13, 20] , the synthesis considered the following factors: (1) study methodological quality (COSMIN scores); (2) the number of studies reporting evidence per PROM; (3) the results for each measurement property for each PROM; and (4) evidence consistency between reviewed studies. Two elements to the data synthesis score are described: First, the overall quality of a measurement property was reported as: adequate (?), not adequate (-), conflicting (±), or unclear (?). Second, levels of evidence for the overall quality of each measurement property was categorized as 'strong', 'moderate', 'limited', 'conflicting', or 'unknown' [13, 24] .
Results
Identification of studies and PROMs
The initial searches (conducted 1980 to July 2012) generated more than 9000 articles (Fig. 1) . Following title and abstract assessment, 177 articles were reviewed in full, including eight from citation searches. Update searches (conducted August 2015) generated a further 934 articles; title and abstract assessment resulted in a further 50 articles for full review (Fig. 1) . No additional articles were identified from updated citation searches.
A total of 71 articles were included in the review ( Fig. 1 Tables 1, 2, Table 1 ). It was frequently impossible to include measures due to inadequate descriptions or lack of reference.
Characteristics of reviewed measures
Twelve generic measures of health status, quality of life or capability were reviewed. Six were profile measures: the COOP-WONCA charts [25] , Nottingham health profile (NHP) [26] , quality of life scale (QoLS) [27] , short-form 36-item health survey (version 1) (SF-36 v1) [28] , the SF- 12 (SF-12) (version 1) [29] , and the World Health Organization quality of life questionnaire-short form (WHO-QOL-BREF) [30] ; and one single-item measure of quality of life-the EuroQol EQ-thermometer (EQ-VAS) [31] . Four were preference-based utility measures: EuroQoL EQ-5D 3L [31] , Health Utility Index 2 (HUI-2) [32] and 3 (HUI-3) [33] , and the SF-6D derived from completion of the SF-36 or SF-12 [34] . One measure-the ICEpop CAPability measure for older people (ICECAP-O), is an older-people-specific profile measure of capability and well-being for application in economic evaluations [35] .
Three hip-specific measures were reviewed. Two measures-the Charnley hip score (CHS) [36] and the Harris hip score (HHS) [37] -were designed to be administered by a qualified health professional. They were included in the review due to their widespread use and the inclusion of several patient-based items (pain, mobility, functional activities): it was often difficult to discern how these particular items were completed and the relative contribution of patients to the assessment. The Oxford hip score (OHS) [38] is the only patient-completed hip-specific assessment, developed for the assessment of pain and functional ability The data synthesis score has two elements. First, the overall quality of a measurement property was reported as: adequate (?), not adequate (-), conflicting (±), or unclear (?). Second, levels of evidence for the overall quality of each measurement property were further defined to indicate 'strong'-consistent findings in multiple studies of good methodological quality or in one study of excellent quality; 'moderate'-consistent findings in multiple studies of fair methodological quality OR in one study of good methodological quality; 'limited'-one study of fair methodological quality; 'conflicting'-conflicting findings; or 'unknown' evidence-only studies of poor methodological quality (detailed by Nilsdotter & Bremander [12] ; Conijn et al. [22] )
n/a Non-applicable a Data synthesis: the data were qualitatively synthesized to determine the overall quality of measurement properties and acceptability of each reviewed PROM. The synthesis took the following factors into account: (1) methodological quality of the reviewed studies (COSMIN scores); (2) the number of studies reporting evidence of measurement properties per PROM; (3) the results for each measurement property for each PROM; and (4) [40] were reviewed.
Additionally, 11 domain-specific measures were reviewed: three measures of emotional well-being-geriatric depression scale (GDS) [41] , Hamilton rating scale for depression (HAM-D) [42] and the Zung depression inventory (ZungDI) [43] ; and eight measures of (instrumental) activities of daily living (I/ADL): Barthel index (BI) [44] , modified Barthel index [45] , functional activities index (FAI) [46] , functional independence measure (FIM) [47] , functional status questionnaire (FSQ) [48] , Lawton IADL scale (Lawton IADL) [49] , Katz index of independence in ADL (Katz ADL) [50] and the OARS multi-dimensional functional assessment questionnaire (OMFAQ) [51] . One of these measures (Katz ADL) is cliniciancompleted, but was included in the review due to its widespread use in this patient population. Although most often clinician-completed, the original and modified versions of the Barthel index can be self-completed by patients and hence were included in the review.
Patient and study characteristics
Characteristics of included studies are detailed in the Appendix (Supplementary Appendix Table 1 ). Sample sizes ranged between 25 and more than 13,000. The mean ages of the patient groups ranged from 69 to 87 years. All patients had sustained a hip fracture. The majority of studies excluded cognitively impaired patients. Only two studies specifically evaluated the impact of proxy completion on PROM performance-the HUI [52] and the FIM [53] . The majority of studies were cohort studies; ten were randomized controlled trials. Several PROM comparative evaluations were included [54] [55] [56] [57] [58] [59] [60] [61] .
Measurement properties and methodological quality
PROM measurement properties and methodological quality of reviewed studies are summarized in Supplementary  Table 2 and Table 1 , respectively. Most studies reported validity (mostly known groups), but few studies formulated a priori hypothesized associations between questionnaires in advance of testing or provided any clarity with regard to the way in which missing data was handled, hence the fair or poor methodological quality rating. Eleven studies reported evidence of reliability (Supplementary Table 2 ). With the exception of a just five studies [57, [61] [62] [63] [64] which provided acceptable evidence in support of the longitudinal validity of reviewed measures, evidence of measurement responsiveness was largely lacking (Supplementary Table 2, Table 1 ). Twelve studies generated effect size (ES) statistics (Supplementary Table 2 ). Although reflecting the size of change score rather than responsiveness [18, 65] , where this was accompanied by a clear (or most often assumed) hypothesis detailing the expected direction and size of effect, this evidence was extracted but not included in the final COSMIN-framed synthesis. The majority of studies reported evidence of statistical significance of change scores (for example, paired t-tests and associated p-values); such evidence is an inappropriate reflection of measurement responsiveness and was not included in the review [16] .
Generic measures
The SF-36 (v1) is the most widely evaluated measure in this population group, with moderate-to-strong evidence supporting measurement validity and responsiveness (Supplementary Table 2, Table 1 ) to change in health following surgical repair of a hip fracture. There is moderate evidence of internal consistency, with some limited evidence of test-retest reliability. Evaluations of the revised SF-36 (version 2) were not identified.
Although lacking evidence of reliability, the EuroQoL EQ-5D 3L has moderate evidence supporting its validity (mostly known groups) and responsiveness. A strong correlation between the EQ-5D 3L and the OHS has been reported (range 0.70-0.74) [54, 66] . Acceptable evidence of responsiveness has been reported following surgical repair of hip fracture (for example, [57, 59, 67] ) (Supplementary Table 2, Table 1 ). Large standardized effect sizes (range 0.64-0.68) have been reported in two large UKbased patient cohorts in the initial 4-to 6-week follow-up period; much smaller values were reported over the longer term (ES range 0.27 at 1 year to 0.32 at 12-weeks) [54, 66] . Acceptable evidence supports the discriminative ability of the EQ-5D: for example, between-groups defined by the external clinical criterion 'good versus less good clinical outcome' [57] . Few studies provide evidence of change score correlations: where reported between the EQ-5D and SF-36 domains, correlations ranged from 0.03 to 0.45, the strongest being between the EQ-5D index score and the SF-36 domains such as body pain, vitality, and physical function [57] .
There were few comparative evaluations of generic measures. Evidence of validity was equally supportive of the SF-36 and EQ-5D [57] , although evidence suggests that the EQ-5D may be more responsive where substantial change in health is expected [57] . Comparable ES statistics were reported for the COOP-WONCA charts and the NHP [58] at 4 months post-hip-fracture, and for the HUI-2 and HUI-3 at 6 months post-hip fracture [62] . For the remaining generic measures, there is little, conflicting, or no evidence of measurement reliability, validity and responsiveness (Supplementary Table 2, Table 1 ).
Specific measures
Hip-specific
Although widely used, there is no evidence in support of the reliability or responsiveness of the Charnley and Harris hip scores, and evidence of measurement validity is limited. These measures should be used with caution. Three studies provide limited evidence of measurement validity [54, 66, 68] and two report ES statistics [54, 66] for the OHS. Although the hypothesized association between variables was not stated a priori, moderate-to-strong correlations between the OHS and EQ-5D 3L and comparable ES statistics were reported at 4 weeks [ES 1.14 (OHS)] and 4-months [ES 0.39 (OHS)] post-op. By comparison, small ES statistics were reported for the ICECAP-O at all followup points of the same study; correlations with both the OHS and EQ-5D were small [54] . Further comparative evaluations of the OHS, including rigorous evidence of responsiveness (for example, correlation of change scores), relevance and acceptability are required to increase confidence in future applications.
Disease-specific
Although widely evaluated in other conditions, the two disease-specific measures (OPAQ2 and WOMAC) have not been widely evaluated in this population group: there is no evidence of measurement reliability and unknown or limited evidence of validity. Whilst large effect ES have been reported for the OPAQ2 physical and social activity domains at 12 months post-hip fracture, small ES were reported for the back pain and tension domains [69] . The OPAQ2 was developed for use with postmenopausal women and so may have limited applicability in the wider hip-fracture population. These measures should be used with caution until further evidence of essential measurement properties, relevance and acceptability are established.
Domain-specific
These measures were further classified as measures of emotional well-being (4), and measures of (instrumental) activities of daily living (I/ADL)(8).
Emotional well-being
The most widely evaluated measure was the 30-item Geriatric Depression Scale (GDS). However, evidence of the reliability, validity and responsiveness of the GDS in this group is very limited and further applications should be made with caution. Moreover, evidence suggests limited acceptability of the GDS following interview administration due to difficulty responding to the 'yes/no' response format and a tendency for responders to 'digress' [70] . Although shorter versions exist, which have recently been recommended for use with older people in the UK [71] , these have not been evaluated following completion by older people sustaining a hip fracture. There is very limited evidence of essential measurement properties for the remaining measures.
Instrumental/Activities of Daily Living
The most widely evaluated measures in this group are the Functional Impact Measure (FIM), the original Barthel Index (BI), and the Katz ADL, with 21, 10, and 8 reviewed evaluations, respectively. Only the BI can be self-completed, but it is most often completed by clinicians. The FIM is interview-administered with a trained clinician, and the Katz ADL is completed by a trained clinician. Although not patient-completed measures, these latter two measures were reviewed due to their widespread use as measures of patient-based outcome. The FIM has good evidence of test-retest reliability, moderate evidence of validity (convergent/divergent and known groups), but limited evidence of responsiveness to change following surgical repair of hip fracture [63] . Evidence of acceptability and feasibility of FIM completion was not reported in this group; although only containing 18 items, administration may require between 30 and 60 min. Moderate evidence supports the validity of the original Barthel Index but evidence of reliability is lacking. Moderate to large ES statistics have been reported at 1, 4, 6 and 12 months posthip-fracture [58, 72] , comparable to values reported for physical mobility domains of the NHP and COOP/ WONCA [58] . Containing only 10 items, the BI can be self-completed in 10 min (not reported in this population) or clinician-completed in between 5 and 10 min, suggesting better acceptability and feasibility than the FIM. Evidence in support of the Katz ADL and the remaining measures of I/ADL measures is very limited: the majority lack any evidence of reliability and responsiveness, and evidence of validity is restricted to poor quality, knowngroups analyses.
Discussion
Despite the large number of studies which now include PROMs in the evaluation of hip fracture in older people, there are disappointingly few robust evaluations from which to draw clear recommendations for PROM selection. Confidence in PROM selection requires evidence of both measurement and practical properties. However, evidence of relevance, test-retest reliability, measurement error, structural validity and score interpretation was not identified for any reviewed measure; just four (SF-36, HUI2, HUI3, FIM) had limited evidence of inter-rater reliability. With the exception of three measures (SF-36, EQ-5D, Barthel Index), evidence of responsiveness was absent or limited. Evidence of acceptability and feasibility was poorly reported; only two studies evaluated the impact of cognitive impairment and the role of proxy completion.
In comparison with earlier PROM reviews for various hip pathologies [4, 5, 10, 12] , the strength of this review lies in the first application of transparent appraisal frameworks supporting evaluations of study [15] and PROM quality [16, 20] in this population. These frameworks highlighted significant methodological and quality concerns which must be addressed in future PROM evaluations if robust recommendations are to be made; this is particularly pertinent to the evaluation of measurement responsiveness. The frameworks were independently applied to all included studies by two reviewers (JB, KH) and agreement checked; however, a limitation of the review is that the synthesis score was applied only by a single reviewer (KH). The grading criterion supports synthesis of large amounts of data but, although applied in several recent reviews [13, 20] , itself lacks robust evidence of reliability and validity and should therefore be cautiously interpreted. Although only English-language publications were included in the review, a wide range of questionnaires and language versions were reviewed and any selection bias is unlikely. However, evidence from different countries and language versions was combined, which may fail to take into consideration any cross-cultural variation in performance and should be considered for future reviews [24] .
The extensive literature search included the major health databases and was further supplemented by reference to existing reviews and recent reports. Although only Englishlanguage studies were included, the diversity of measures and language versions included in the review suggests that any selection bias is unlikely. Reviewed studies included patients with a lower age of 60 years; no upper-age limit was imposed. However, few studies included cognitively impaired patients or explored the impact of such impairment on PROM completion and performance. We are confident that the results are generalizable to the wider population of older people who sustain a hip fracture, but may not represent the experience of patients with varying degrees of cognitive impairment.
In keeping with other reviews (for example, [16, 20] ), the relevance, content or face validity of the reviewed measures has not been reported in the hip fracture population. The relevance or appropriateness of a measure to the target population is a crucial consideration, particularly if the group differs from the population in which the measure was originally developed [21] . Only one measure-the ICECAP-O-is older-people-specific; one measure-the Oxford Hip Score (OHS)-is intervention-specific (total hip replacement); no measure is specific to hip fracture. Qualitative research which seeks to understand what really matters to older people as an outcome from healthcare following hip fracture is essential to informing appropriate question and PROM content [73, 74] . The active collaboration of the older population in the development and/or evaluation of reviewed PROMs-for example, working in partnership to co-produce knowledge-was not reported.
The estimated range of cognitive impairment in older people with hip fracture is between 31 and 88 % (mean 47 %) [45, 75, 76] , often significantly limiting their ability to self-report [69, 77] . Alternative information sources or proxy respondents such as primary caregivers, close relatives, or health professionals, may be utilized. Few studies have explored the relative impact of proxy-completion in this population [74, 78] . However, as observed with older people more generally [79] , evidence suggests that proxy and patient responses are not interchangeable, and agreement is higher for more observable health constructs. Consistency of proxy completer (that is, inter-tester reliability) has not been addressed. Anecdotal evidence suggests that many older patients may lack a consistent named proxy-for example, due to lack of dedicated family member or named/regular health professional. The impact of different proxy respondents for both research and clinical practice settings should be considered.
Only the SF-36 and three I/ADL measures (BI, FAI, FIM) have moderate evidence of both convergent and known-groups validity, with clear evidence of a priori hypothesized associations between variables being explored. With the exception of the EQ-5D and Katz ADL, for which moderate evidence of known-groups validity (and limited convergent for the EQ-5D) was reviewed, the majority of the remaining measures had limited or unknown evidence. The majority of studies simply compared the scores on measures between patients who had sustained a hip fracture and a population-based cohort, or between different types of hip fracture. Evidence of construct validity was limited for all measures by the failure of authors to state a priori hypothesized size and/or direction of associations between variables or known groups. There were no evaluations of structural validity in this population.
Evidence of measurement reliability was very limited; test-retest and measurement error was not reported. Internal consistency reliability was reported only for the SF-36. Limited inter-rater agreement following interview administration of the SF-36 [55] and moderate patientproxy agreement for the HUI-2 and HUI-3 [78] and the FIM [74] was reported.
As reported by other reviewers (for example, [13, 20, 80] ), very few studies with evidence of measurement responsiveness were included. With the exception of the SF-36, EQ-5D, NHP and the FIM evidence of responsiveness were mostly limited or not identified. Although numerous studies described longitudinal change in health or compared the relative benefit of different treatment approaches, the majority reported only the statistical significance of score change. Due to the failure to explore the validity of score change, statistical significance is judged an inappropriate representation of measurement responsiveness [18] . Moreover, due to the difficulties of disentangling issues of responsiveness from the effects of an intervention, judgment on PROM responsiveness in trial-based studies is difficult [18] . Due to the failure to provide a priori hypothesized expectations for the direction and size of score change or correlation, many of the included studies were judged to be of relatively poor methodological quality.
Well-developed PROMs provide essential evidence of the impact of healthcare, contributing the patient perspective to the developing evidence-base. Advances in measurement science and a growing recognition of the importance of capturing the patient perspective have resulted in a substantial growth in PROM availability [81] . However, an historic lack of good practice guidance coupled with a limited requirement for transparency and accountability in PROM development and evaluation has resulted in a large number of measures with dubious development history and limited quality. However, recent internationally endorsed guidance for the transparent development and robust evaluation of PROMs seeks to facilitate the development of high quality, relevant and acceptable PROMs with which to inform decision-making [82] . The end-users of PROMs-including clinicians, health professionals, researchers and patients-should demand that PROM-related data is robust, relevant and acceptable and that accepted standards for development and evaluation have been adhered to.
Evidence-based healthcare requires the judicious integration of best evidence with clinical expertise and patient experience [83] . Establishing 'best evidence' demands the critical appraisal of study methodological quality; therefore, an appreciation of the methodological quality of PROM evaluative studies is crucial to data interpretation. The development of the COSMIN guidance-consensusbased standards for the evaluation of study methodological quality-provides essential and timely guidance to support and inform greater transparency and methodological rigour in PROM evaluation [11, 15] . The future selection of welldeveloped PROMs with evidence of essential measurement and practical properties generated from high-quality studies will ensure that healthcare is underpinned with satisfactory patient-derived evidence, thus reducing the potential for research waste where evidence is founded upon unacceptable evidence.
Outcomes research for traumatic hip fracture urgently requires methodologically rigorous evaluations of relevant and appropriate PROMs. Evidence suggests that the SF-36 and EQ-5D are candidate measures which require further evaluation. Although long, with evidence of poor-selfcompletion rates (version 1), the SF-36 (version 2) revised response options could improve acceptability. The EQ-5D benefits from being short (5 questions), with acceptable completion rates in non-cognitively impaired older people; the revised EQ-5D 5L version has not been evaluated in this population, but the improved response categories may improve both relevance and responsiveness. The EQ-5D is the preferred generic measure to inform quality of care assessment by England's Department of Health [84] and has recently been recommended for inclusion in a core outcome set for hip fracture trials [85] . Future evaluations must pay particular attention to the relevance and acceptability of the measures to the target group, to data quality (including missing data), reliability and responsiveness.
However, evaluating the relative benefit of healthcare in patients representing the frailer end of the spectrum and who experience a range of co-morbidities is challenging. Older, more frail patients often view their limitations as a consequence of ageing, or experience difficulties disentangling the impact of the hip fracture from the wide range of co-morbidities they experience [73] . Similar difficulties associated with the impact of multiple co-morbidities have been reported in other patient populations, for example, in mental health [86] . The often complex and diverse nature of health experienced by this population group highlights the need for a well-crafted, relevant and appropriate measures which capture the broad array of important health domains, and have the option for proxy completion. Moreover, evidence would suggest a benefit to be gained by utilizing both generic and specific measures [78, 87] .
The paucity of robust PROM evaluation in this important, diverse, and growing group, is disappointing and prevents clear recommendations for PROM-based assessment. The active engagement of key stakeholders, including patients, carers' and health professionals, should seek to support more collaborative PROMs-related research, the co-production of knowledge and selection of high-quality measures that are both relevant and appropriate [22] . Identifying the 'best' measures will require robust comparative evaluations of candidate measures and should include generic (including the SF-36 (version 2), the
